Dynavax Technologies | Utile Per Azione



Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q1 Mar/2025 0.0123 -0.07 May/01 2025
FY2024Q4 Dec/2024 0.05 0.04 Feb/20 2025
FY2024Q3 Sep/2024 0.12 0.12 0.10 Nov/07 2024
FY2024Q2 Jun/2024 0.08 0.06 0.03 Aug/06 2024
FY2024Q1 Mar/2024 -0.07 -0.02 -0.19 May/08 2024
FY2023Q4 Dec/2023 -0.03 0.45 Feb/22 2024
FY2023Q3 Sep/2023 0.10 -0.04 0.43 Nov/02 2023
FY2023Q2 Jun/2023 0.03 -0.09 0.87 Aug/03 2023
FY2023Q1 Mar/2023 -0.19 -0.13 0.22 May/02 2023
FY2022Q4 Dec/2022 0.45 0.43 0.55 Feb/23 2023
FY2022Q3 Sep/2022 0.43 0.34 -0.24 Nov/03 2022
FY2022Q2 Jun/2022 0.87 0.22 0.02 Aug/04 2022

Eps Cambiamento Data
AbbVie USD 2.16 0.84 2024-12
Adma Biologics USD 0.14 0.01 2024-12
Amgen USD 5.31 0.27 2024-12
AstraZeneca USD 2.09 0.01 2024-12
Biogen USD 3.44 0.64 2024-12
BioMarin Pharmaceutical USD 0.64 0.09 2024-12
Bristol-Myers Squibb USD 1.67 0.13 2024-12
Dynavax Technologies USD 0.05 0.07 2024-12
Gilead Sciences USD 1.9 0.12 2024-12
Glaxosmithkline USD 0.59 0.7 2024-12
Merck USD 1.72 0.15 2024-12
Neurocrine Biosciences USD 1 0.24 2024-12
Novartis USD 1.98 0.4 2024-12
Pfizer USD 0.63 0.43 2024-12
Regeneron Pharmaceuticals USD 12.07 0.39 2024-12
Roche Holding CHF 8.57 1.66 2024-12
Sarepta Therapeutics USD 1.5 1.16 2024-12
TG Therapeutics USD 0.15 0.13 2024-12
Vertex Pharmaceuticals USD 3.98 0.4 2024-12



Dynavax Technologies Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.